5 employees
PaxMedica is a biopharmaceutical company focused on developing innovative treatments for unmet needs in neurodevelopmental disorders.
2018
$20M
from 2 investors over 2 rounds
PaxMedica raised $3.7M on February 3, 2023
Investors: The Lind Partners, LLC
PaxMedica raised $20M on November 17, 2022
Investors: Lincoln Park Capital, LLC